A Safety and Tolerability Study of PCI-24781 in Subjects With Cancer

Clinical trial NCT01149668 · COMPLETED

Trial details

NCT number: NCT01149668
Sponsor: Pharmacyclics LLC.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Lymphoma Non-Hodgkin's Lymphoma Hodgkin Disease Multiple Myeloma Leukemia Lymphocytic

Start date: 2010-06-01
Primary completion: 2012-12-01
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.